This company has been marked as potentially delisted and may not be actively trading. Ocean Biomedical (OCEA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesOptions ChainShort InterestTrendsBuy This Stock OCEA vs. EGRX, CLRB, EDSA, CMMB, BFRG, SCNX, NXTC, GLYC, BOLT, and BCTXShould you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include Eagle Pharmaceuticals (EGRX), Cellectar Biosciences (CLRB), Edesa Biotech (EDSA), Chemomab Therapeutics (CMMB), Bullfrog AI (BFRG), Scienture (SCNX), NextCure (NXTC), GlycoMimetics (GLYC), Bolt Biotherapeutics (BOLT), and BriaCell Therapeutics (BCTX). These companies are all part of the "pharmaceutical preparations" industry. Ocean Biomedical vs. Eagle Pharmaceuticals Cellectar Biosciences Edesa Biotech Chemomab Therapeutics Bullfrog AI Scienture NextCure GlycoMimetics Bolt Biotherapeutics BriaCell Therapeutics Eagle Pharmaceuticals (NASDAQ:EGRX) and Ocean Biomedical (NASDAQ:OCEA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, dividends, media sentiment, risk and earnings. Which has more risk & volatility, EGRX or OCEA? Eagle Pharmaceuticals has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Ocean Biomedical has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Does the media prefer EGRX or OCEA? In the previous week, Ocean Biomedical had 2 more articles in the media than Eagle Pharmaceuticals. MarketBeat recorded 6 mentions for Ocean Biomedical and 4 mentions for Eagle Pharmaceuticals. Eagle Pharmaceuticals' average media sentiment score of 0.43 beat Ocean Biomedical's score of 0.00 indicating that Eagle Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eagle Pharmaceuticals 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Ocean Biomedical 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, EGRX or OCEA? Eagle Pharmaceuticals has higher revenue and earnings than Ocean Biomedical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEagle Pharmaceuticals$257.55M0.08$35.64MN/AN/AOcean BiomedicalN/AN/A-$114.47M-$0.94-0.06 Do insiders and institutionals believe in EGRX or OCEA? 85.4% of Eagle Pharmaceuticals shares are owned by institutional investors. Comparatively, 24.6% of Ocean Biomedical shares are owned by institutional investors. 28.9% of Eagle Pharmaceuticals shares are owned by insiders. Comparatively, 73.5% of Ocean Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is EGRX or OCEA more profitable? Company Net Margins Return on Equity Return on Assets Eagle PharmaceuticalsN/A N/A N/A Ocean Biomedical N/A N/A -931.55% Does the MarketBeat Community favor EGRX or OCEA? Eagle Pharmaceuticals received 408 more outperform votes than Ocean Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ocean Biomedical an outperform vote while only 66.13% of users gave Eagle Pharmaceuticals an outperform vote. CompanyUnderperformOutperformEagle PharmaceuticalsOutperform Votes41266.13% Underperform Votes21133.87% Ocean BiomedicalOutperform Votes4100.00% Underperform VotesNo Votes SummaryEagle Pharmaceuticals beats Ocean Biomedical on 6 of the 10 factors compared between the two stocks. Remove Ads Get Ocean Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OCEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCEA vs. The Competition Export to ExcelMetricOcean BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.86M$6.76B$5.57B$7.94BDividend YieldN/A2.81%5.35%4.04%P/E Ratio-0.057.2023.5718.83Price / SalesN/A204.84369.2389.78Price / CashN/A65.6738.1634.64Price / Book-0.026.116.694.19Net Income-$114.47M$142.11M$3.20B$247.10M Ocean Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCEAOcean Biomedical0.6356 of 5 stars$0.06-91.0%N/A-98.6%$4.86MN/A-0.05N/AEGRXEagle PharmaceuticalsN/A$1.45-2.7%N/A-67.5%$18.83M$257.55M0.00100News CoverageGap UpCLRBCellectar Biosciences1.9325 of 5 stars$0.39+5.7%$17.67+4,427.6%-92.6%$17.98MN/A-0.2310Short Interest ↑EDSAEdesa Biotech2.6142 of 5 stars$2.56+2.4%$21.00+720.3%-45.9%$17.90MN/A-1.3720Gap UpCMMBChemomab Therapeutics3.4565 of 5 stars$1.24-3.1%$9.00+625.8%+35.9%$17.81MN/A-1.2420Short Interest ↓BFRGBullfrog AI1.3732 of 5 stars$1.89+7.4%N/A-45.4%$17.79M$60,000.00-2.224Upcoming EarningsPositive NewsGap DownSCNXScientureN/A$1.91-5.0%N/AN/A$17.17M$7.12M0.00N/AGap DownNXTCNextCure3.6284 of 5 stars$0.61+6.8%$3.50+474.7%-81.1%$17.06MN/A-0.2990Gap DownGLYCGlycoMimetics1.3291 of 5 stars$0.26-2.3%$8.00+2,933.8%-93.4%$17.01M$10,000.000.0050Analyst ForecastBOLTBolt Biotherapeutics3.5098 of 5 stars$0.44-0.3%$1.25+185.6%-74.5%$16.75M$9.78M-0.2690Gap UpBCTXBriaCell Therapeutics1.2477 of 5 stars$4.46-0.2%$32.00+617.5%-91.8%$16.54MN/A-0.338Gap Up Remove Ads Related Companies and Tools Related Companies EGRX Alternatives CLRB Alternatives EDSA Alternatives CMMB Alternatives BFRG Alternatives SCNX Alternatives NXTC Alternatives GLYC Alternatives BOLT Alternatives BCTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCEA) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocean Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
